Immuneering Corporation (IMRX) NASDAQ
4.28
-0.215(-4.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.28
-0.215(-4.78%)
Currency In USD
| Market Cap | 289.6M |
| Enterprise Value | 164.78M |
| P/E Ratio | -3.46 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 738.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -698,887 |
| EBITDA | -58.68M |
| Net Income | -56.02M |
| Diluted EPS | -1.27 |
| Total Cash | 156.69B |
| Total Cash/Share | 3,560.26 |
| Total Debt | 3.73B |
| Total Debt/Equity | 0.02 |
| Current Ratio | 32.45 |
| Book Value Per Share | 4,692.33 |
| 52-Week Change | 128.88 |
| 52-Week High | 10.08 |
| 52-Week Low | 1.66 |
| Moving Average 50 Days | 5.34 |
| Moving Average 200 Days | 5.82 |
| Average Volume | 1.27M |
| Shares Outstanding | 36.3M |
| % Held by Institutions | 66.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |